Sixty Years of Drug Discovery for Type 2 Diabetes: Where Are We Now?
Author:
Publisher
Springer New York
Link
http://link.springer.com/content/pdf/10.1007/978-1-4939-9882-1_1
Reference226 articles.
1. Sugiyama Y (2005) Druggability: selecting optimized drug candidates. Drug Discov Today 10:1577–1579
2. Allen MJ, Carey AH (2004) Target identification and validation through genetics. Drug Discov Today TARGETS 3:183–190
3. Sams-Dodd F (2005) Target-based drug discovery: is something wrong? Drug Discov Today 10:139–147
4. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, Schact AL (2010) How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov 9:203–214
5. Bouzakri K, Koistinen HA, Zierath JR (2005) Molecular mechanisms of skeletal muscle insulin resistance in type 2 diabetes. Curr Diabetes Rev 1:167–174
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chickpea (Cicer arietinum) protein hydrolysate ameliorates metabolic effects of feeding a high-fat diet to mice;Journal of Functional Foods;2024-10
2. Improvement effect of a next-generation probiotic L. plantarum-pMG36e-GLP-1 on type 2 diabetes mellitus via the gut–pancreas–liver axis;Food & Function;2023
3. Therapeutic Strategies Targeting Pancreatic Islet β-Cell Proliferation, Regeneration, and Replacement;Endocrinology;2022-11-14
4. Current and future approaches for in vitro hit discovery in diabetes mellitus;Drug Discovery Today;2022-10
5. NMDA Receptor Antagonists Increase the Release of GLP-1 From Gut Endocrine Cells;Frontiers in Pharmacology;2022-04-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3